Reversible blockade of thymic output: An inherent part of TLR ligand-mediated immune response

Journal of Immunology

Volumn 181, Issue 10, 2008, Pages 6757-6769

  Démoulins, Thomas ^a,b   Abdallah, Ali ^a,b   Kettaf, Nadia ^a,b   Baron, Marie Laurence ^a,b   Gerarduzzi, Casimiro ^a   Gauchat, Dominique ^a,b   Gratton, Sophie ^a,b   Sékaly, Rafick Pierre ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INTERFERON; POLYINOSINIC POLYCYTIDYLIC ACID; RAG2 PROTEIN; RNA; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR; ANTIVIRUS AGENT; LIGAND; LYMPHOCYTE ANTIGEN RECEPTOR; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL MATURATION; CELL PROLIFERATION; CELL SUBPOPULATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; IMMUNE RESPONSE; IMMUNOMODULATION; MOLECULAR SENSOR; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; THYMOCYTE; THYMUS; UPREGULATION; VIRUS INFECTION; ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; CYTOLOGY; FLOW CYTOMETRY; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; MOUSE MUTANT; PATHOLOGY; POLYMERASE CHAIN REACTION;

ANIMALS; ANTIVIRAL AGENTS; APOPTOSIS; CELL DIFFERENTIATION; FEMALE; FLOW CYTOMETRY; LIGANDS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; POLY I-C; POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL; RNA, VIRAL; T-LYMPHOCYTES; THYMUS GLAND; TOLL-LIKE RECEPTORS;

EID: 58149184316     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.10.6757     Document Type: Article

References (68)

1. Biron, C. A. 1998. Role of early cytokines, including α and β interferons (IFN-α/β), in innate and adaptive immune responses to viral infections. Semin. Immunol. 10: 383-390.
2. Pestka, S., C. D. Krause, and M. R. Walter. 2004. Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 202: 8-32. (Pubitemid 39576902)
3. Guidotti, L. G., and F. V. Chisari. 2001. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19: 65-91. (Pubitemid 32368030)
4. Tanaka, N., M. Sato, M. S. Lamphier, H. Nozawa, E. Oda, S. Noguchi, R. D. Schreiber, Y. Tsujimoto, and T. Taniguchi. 1998. Type I interferons are essential mediators of apoptotic death in virally infected cells. Genes Cells 3: 29-37. (Pubitemid 28374995)
5. Biron, C. A. 2001. Interferons α and β as immune regulators: a new look. Immunity 14: 661-664.
6. Samuel, C. E. 2001. Antiviral actions of interferons. Clin. Microbiol. Rev. 14: 778-809.
7. Taniguchi, T., and A. Takaoka. 2002. The interferon-α/β system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr. Opin. Immunol. 14: 111-116. (Pubitemid 34085114)
8. Cella, M., M. Salio, Y. Sakakibara, H. Langen, I. Julkunen, and A. Lanzavecchia. 1999. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 189: 821-829. (Pubitemid 29189687)
9. Grakoui, A., N. H. Shoukry, D. J. Woollard, J. H. Han, H. L. Hanson, J. Ghrayeb, K. K. Murthy, C. M. Rice, and C. M. Walker. 2003. HCV persistence and immune evasion in the absence of memory T cell help. Science 302: 659-662. (Pubitemid 37310924)
10. Lechner, F., D. K. Wong, P. R. Dunbar, R. Chapman, R. T. Chung, P. Dohrenwend, G. Robbins, R. Phillips, P. Klenerman, and B. D. Walker. 2000. Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 191: 1499-1512. (Pubitemid 30257347)
11. McMichael, A. J., and S. L. Rowland-Jones. 2001. Cellular immune responses to HIV. Nature 410: 980-987.
12. Rickinson, A. B., and D. J. Moss. 1997. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu. Rev. Immunol. 15: 405-431. (Pubitemid 27169287)
13. + T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J. Virol. 77: 68-76.
14. Ward, S., G. Lauer, R. Isba, B. Walker, and P. Klenerman. 2002. Cellular immune responses against hepatitis C virus: the evidence base 2002. Clin. Exp. Immunol. 128: 195-203. (Pubitemid 34534031)
15. Kolumam, G. A., S. Thomas, L. J. Thompson, J. Sprent, and K. Murali-Krishna. 2005. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 202: 637-650.
16. + T lymphocytes during primary response. J. Immunol. 173: 3740-3747.
17. Lin, Q., C. Dong, and M. D. Cooper. 1998. Impairment of T and B cell development by treatment with a type I interferon. J. Exp. Med. 187: 79-87. (Pubitemid 28044822)
18. Keir, M. E., C. A. Stoddart, V. Linquist-Stepps, M. E. Moreno, and J. M. McCune. 2002. IFN-α secretion by type 2 predendritic cells up-regulates MHC class I in the HIV-1-infected thymus. J. Immunol. 168: 325-331.
19. Baron, M. L., D. Gauchat, R. La Motte-Mohs, N. Kettaf, A. Abdallah, T. Michiels, J. C. Zúñiga-Pflücker, and R. P. Sékaly. 2008. TLR ligands induced type I IFNs affect thymopoiesis. J. Immunol. 180: 7134-7146.
20. Schmidlin, H., W. Dontje, F. Groot, S. J. Ligthart, A. D. Colantonio, M. E. Oud, E. J. Schilder-Tol, M. Spaargaren, H. Spits, C. H. Uittenbogaart, and B. Blom. 2006. Stimulated plasmacytoid dendritic cells impair human T-cell development. Blood 108: 3792-3800. (Pubitemid 44864561)
21. Morris, A., and I. Zvetkova. 1997. Cytokine research: the interferon paradigm. J. Clin. Pathol. 50: 635-639.
22. Gresser, I. 1997. Wherefore interferon? J. Leukocyte Biol. 61: 567-574. (Pubitemid 27234453)
23. Honda, K., and T. Taniguchi. 2006. Toll-like receptor signaling and IRF transcription factors. IUBMB Life 58: 290-295. (Pubitemid 43880018)
24. Muller, U., U. Steinhoff, L. F. Reis, S. Hemmi, J. Pavlovic, R. M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921. (Pubitemid 24245635)
25. + natural regulatory T cells revealed by DNA microarray analysis. Int. Immunol. 18: 1197-1209.
26. Pannetier, C., M. Cochet, S. Darche, A. Casrouge, M. Zoller, and P. Kourilsky. 1993. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor β chains vary as a function of the recombined germ-line segments. Proc. Natl. Acad. Sci. USA 90: 4319-4323. (Pubitemid 23134218)
27. - NKT cells with distinct TCR αβ repertoires and differential distribution in lymphoid tissues. J. Immunol. 165: 2481-2490.
28. Gallimore, A., A. Glithero, A. Godkin, A. C. Tissot, A. Pluckthun, T. Elliott, H. Hengartner, and R. Zinkernagel. 1998. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J. Exp. Med. 187: 1383-1393. (Pubitemid 28215398)
29. McNally, J. M., C. C. Zarozinski, M. Y. Lin, M. A. Brehm, H. D. Chen, and R. M. Welsh. 2001. Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses. J. Virol. 75: 5965-5976.
30. Wherry, E. J., T. C. Becker, D. Boone, M. K. Kaja, A. Ma, and R. Ahmed. 2002. Homeostatic proliferation but not the generation of virus specific memory CD8 T cells is impaired in the absence of IL-15 or IL-15Rα. Adv. Exp. Med. Biol. 512: 165-175.
31. Dion, M. L., J. F. Poulin, R. Bordi, M. Sylvestre, R. Corsini, N. Kettaf, A. Dalloul, M. R. Boulassel, P. Debre, J. P. Routy, et al. 2004. HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation. Immunity 21: 757-768.
32. + T-cell depletion in HIV disease. Nature 410: 974-979.
33. Currier, N. L., and S. C. Miller. 1998. Influence of an interferon inducer on bone marrow transplant reconstitution in irradiated, leukemic mice: elevated natural killer cell numbers and improved life span. Nat. Immun. 16: 6-17.
34. Herbst-Kralovetz, M. M., and R. B. Pyles. 2006. Quantification of poly(I:C)-mediated protection against genital herpes simplex virus type 2 infection. J. Virol. 80: 9988-9997. (Pubitemid 44522593)
35. Moriyama, H., L. Wen, N. Abiru, E. Liu, L. Yu, D. Miao, R. Gianani, F. S. Wong, and G. S. Eisenbarth. 2002. Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin selfpeptide. Proc. Natl. Acad. Sci. USA 99: 5539-5544. (Pubitemid 34411584)
36. Ewel, C. H., D. O. Sobel, B. J. Zeligs, and J. A. Bellanti. 1992. Poly I:C accelerates development of diabetes mellitus in diabetes-prone BB rat. Diabetes 41: 1016-1021.
37. Sobel, D. O., D. Goyal, B. Ahvazi, J. W. Yoon, Y. H. Chung, A. Bagg, and D. M. Harlan. 1998. Low dose poly I:C prevents diabetes in the diabetes prone BB rat. J. Autoimmun. 11: 343-352.
38. Guggenheim, M. A., and S. Baron. 1977. Clinical studies of an interferon inducer, polyriboinosinic-polyribocytidylic acid [poly(I)-poly(C)], in children. J. Infect. Dis. 136: 50-58.
39. Dalod, M., T. P. Salazar-Mather, L. Malmgaard, C. Lewis, C. Asselin-Paturel, F. Briere, G. Trinchieri, and C. A. Biron. 2002. Interferon α/β and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J. Exp. Med. 195: 517-528. (Pubitemid 34461304)
40. Gil, M. P., R. Salomon, J. Louten, and C. A. Biron. 2006. Modulation of STAT1 protein levels: a mechanism shaping CD8 T-cell responses in vivo. Blood 107: 987-993.
41. Brewer, J. A., O. Kanagawa, B. P. Sleckman, and L. J. Muglia. 2002. Thymocyte apoptosis induced by T cell activation is mediated by glucocorticoids in vivo. J. Immunol. 169: 1837-1843. (Pubitemid 34857645)
42. Brewer, J. A., K. E. Bethin, M. L. Schaefer, L. M. Muglia, S. K. Vogt, S. C. Weninger, J. A. Majzoub, and L. J. Muglia. 2003. Dissecting adrenal and behavioral responses to stress by targeted gene inactivation in mice. Stress 6: 121-125.
43. Porritt, H. E., L. L. Rumfelt, S. Tabrizifard, T. M. Schmitt, J. C. Zuniga-Pflucker, and H. T. Petrie. 2004. Heterogeneity among DN1 prothymocytes reveals multiple progenitors with different capacities to generate T cell and non-T cell lineages. Immunity 20: 735-745.
44. Tough, D. F., P. Borrow, and J. Sprent. 1996. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272: 1947-1950. (Pubitemid 26234507)
45. Chawla-Sarkar, M., D. J. Lindner, Y. F. Liu, B. R. Williams, G. C. Sen, R. H. Silverman, and E. C. Borden. 2003. Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 8: 237-249. (Pubitemid 36749609)
46. Wurch, A., J. Biro, A. J. Potocnik, I. Falk, H. Mossmann, and K. Eichmann. 1998. Requirement of CD3 complex-associated signaling functions for expression of rearranged T cell receptor β VDJ genes in early thymic development. J. Exp. Med. 188: 1669-1678. (Pubitemid 28516112)
47. Marodon, G., and B. Rocha. 1994. Generation of mature T cell populations in the thymus: CD4 or CD8 down-regulation occurs at different stages of thymocyte differentiation. Eur. J. Immunol. 24: 196-204. (Pubitemid 24014699)
48. Feng, C., K. J. Woodside, B. A. Vance, D. El-Khoury, M. Canelles, J. Lee, R. Gress, B. J. Fowlkes, E. W. Shores, and P. E. Love. 2002. A potential role for CD69 in thymocyte emigration. Int. Immunol. 14: 535-544. (Pubitemid 34649709)
49. Nakayama, T., D. J. Kasprowicz, M. Yamashita, L. A. Schubert, G. Gillard, M. Kimura, A. Didierlaurent, H. Koseki, and S. F. Ziegler. 2002. The generation of mature, single-positive thymocytes in vivo is dysregulated by CD69 blockade or overexpression. J. Immunol. 168: 87-94. (Pubitemid 34014106)
50. Shiow, L. R., D. B. Rosen, N. Brdickova, Y. Xu, J. An, L. L. Lanier, J. G. Cyster, and M. Matloubian. 2006. CD69 acts downstream of interferon-α/ β to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440: 540-544.
51. Boursalian, T. E., J. Golob, D. M. Soper, C. J. Cooper, and P. J. Fink. 2004. Continued maturation of thymic emigrants in the periphery. Nat. Immunol. 5: 418-425.
52. Vidalain, P. O., D. Laine, Y. Zaffran, O. Azocar, C. Servet-Delprat, T. F. Wild, C. Rabourdin-Combe, and H. Valentin. 2002. Interferons mediate terminal differentiation of human cortical thymic epithelial cells. J. Virol. 76: 6415-6424.
53. Zamisch, M., B. Moore-Scott, D. M. Su, P. J. Lucas, N. Manley, and E. R. Richie. 2005. Ontogeny and regulation of IL-7-expressing thymic epithelial cells. J. Immunol. 174: 60-67. (Pubitemid 40007392)
54. Phillips, J. A., T. I. Brondstetter, C. A. English, H. E. Lee, E. L. Virts, and M. L. Thoman. 2004. IL-7 gene therapy in aging restores early thymopoiesis without reversing involution. J. Immunol. 173: 4867-4874.
55. Rossi, S., B. R. Blazar, C. L. Farrell, D. M. Danilenko, D. L. Lacey, K. I. Weinberg, W. Krenger, and G. A. Hollander. 2002. Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease. Blood 100: 682-691. (Pubitemid 34761136)
56. Panaretakis, T., K. Pokrovskaja, M. C. Shoshan, and D. Grander. 2003. Interferon-α-induced apoptosis in U266 cells is associated with activation of the proapoptotic Bcl-2 family members Bak and Bax. Oncogene 22: 4543-4556. (Pubitemid 36920698)
57. Hutcheson, J., J. C. Scatizzi, E. Bickel, N. J. Brown, P. Bouillet, A. Strasser, and H. Perlman. 2005. Combined loss of proapoptotic genes Bak or Bax with Bim synergizes to cause defects in hematopoiesis and in thymocyte apoptosis. J. Exp. Med. 201: 1949-1960. (Pubitemid 41002931)
58. Town, T., D. Jeng, L. Alexopoulou, J. Tan, and R. A. Flavell. 2006. Microglia recognize double-stranded RNA via TLR3. J. Immunol. 176: 3804-3812. (Pubitemid 43364029)
59. Park, C., S. Lee, I. H. Cho, H. K. Lee, D. Kim, S. Y. Choi, S. B. Oh, K. Park, J. S. Kim, and S. J. Lee. 2006. TLR3-mediated signal induces proinflammatory cytokine and chemokine gene expression in astrocytes: differential signaling mechanisms of TLR3-induced IP-10 and IL-8 gene expression. Glia 53: 248-256. (Pubitemid 43221347)
60. Salem, M. L., A. N. Kadima, D. J. Cole, and W. E. Gillanders. 2005. Defining the antigen-specific T-cell response to vaccination and poly(I:C)/TLR3 signaling: evidence of enhanced primary and memory CD8 T-cell responses and antitumor immunity. J. Immunother. 28: 220-228.
61. -) subset. J. Immunol. 165: 5621-5630.
62. Fayad, R., J. A. Sennello, S. H. Kim, M. Pini, C. A. Dinarello, and G. Fantuzzi. 2005. Induction of thymocyte apoptosis by systemic administration of concanavalin A in mice: role of TNF-α, IFN-γ and glucocorticoids. Eur. J. Immunol. 35: 2304-2312. (Pubitemid 41179751)
63. Cabaniols, J. P., N. Fazilleau, A. Casrouge, P. Kourilsky, and J. M. Kanellopoulos. 2001. Most α/β T cell receptor diversity is due to terminal deoxynucleotidyl transferase. J. Exp. Med. 194: 1385-1390.
64. Takano, S., H. Nakamura, H. Mita, and Y. Nagano. 1984. Disappearance of terminal deoxynucleotidyltransferase in human malignant T-lymphoblasts treated with a human α interferon preparation. Microbiol. Immunol. 28: 1111-1115. (Pubitemid 15200977)
65. Fazilleau, N., J. P. Cabaniols, F. Lemaitre, I. Motta, P. Kourilsky, and J. M. Kanellopoulos. 2005. Vα and Vβ public repertoires are highly conserved in terminal deoxynucleotidyl transferase-deficient mice. J. Immunol. 174: 345-355. (Pubitemid 40007422)
66. E integrin-positive and CC chemokine ligand 25 responsive. J. Immunol. 172: 7282-7288.
67. Nanda, N. K., R. Apple, and E. Sercarz. 1991. Limitations in plasticity of the T-cell receptor repertoire. Proc. Natl. Acad. Sci. USA 88: 9503-9507.
68. Woodland, D. L., B. L. Kotzin, and E. Palmer. 1990. Functional consequences of a T cell receptor Dβ2 and Jβ2 gene segment deletion. J. Immunol. 144: 379-385.